Hengrui Medicine (01276) signed a strategic cooperation and licensing agreement with Roche.

Intelligence Finance APP news, Hutchison Medicine (01276) announced that Jiangsu Hutchison Medicine Co., Ltd. (hereinafter referred to as "the Company" or "Hutchison") has reached a global strategic cooperation and licensing agreement with Bristol-Myers Squibb Company (hereinafter referred to as "BMS") to jointly promote 13 early-stage projects covering oncology, hematology, and immunology to accelerate the development of innovative drugs and benefit patients worldwide.